[ad_1]
<div id = "firstBodyDiv" data-bind-html-content-type = "article" data-bind-html-compile = "article.body" data-first-article-body = "
The newspaper reported "Haaretz reported" Sunday, that the Israeli Ministry of Health has approved the use of this drug, after studies have revealed a promising link between him and the treatment. Post-traumatic stress disorder.
She noted that it was being developed "The Ecstasy" Its Scientific Name "Or MMA" Be available for patients outside of clinical trials, and was chosen for the absence of 39, effective alternatives.
The drug was invented by a German company in 1912 and used by the German army to curb the appetite of its soldiers.It was used as a psychotropic drug in the 1970s. "Medicine Concert" As many of disco enthusiasts use it.
It drowns the drugs The nervous system Serotonin, a hormone that gives users a sense of euphoria, can last for several hours. It is generally used at night by party animals, because it keeps them awake and vital, despite its damage, such as memory problems, sleep disorders, etc.
First experience
According to "Haaretz reported" The new drug was approved to be given to 50 patients in Israel according to a deliberate program for people suffering from PTSD, the program was launched within six months, with the expectation of receiving hundreds requests.
Among those suffering from PTSD, there are soldiers returning from battlefields, and one study found that 11 to 20 per cent of US soldiers serving in Iraq were suffering from PTSD.
The reasons for the decision
The decision to rely on "Ecstasy" After the Israeli Ministry of Health conducted an intensive investigation and sent representatives to train United States, Especially in an association specializing in psychological studies, and after reviewing the results of studies on the impact of positive drugs.
He is likely to recognize Israel Even before the United States, which should recognize it in 2021, notes that US Food and Drug Administration You are testing it now.
A study published in 2018 concluded to be addressed "Hallucinogenic Drugs" Regularly reduced the symptoms of the disease, which was a shock.
">
According to the newspaper "Haaretz" Sunday, the Israeli Ministry of Health approved the use of this drug, after studies have revealed a promising link between him and the treatment of post-traumatic stress disorder.
She indicated that the development of "Ecstasy" and its scientific name "MDMA" should be available to patients outside of clinical trials and that it had been chosen for the lack of solutions effective replacement.
The drug was invented by a German company in 1912 and used by the German army to curb the appetite of its soldiers. It was used as a psychopath in the 1970s to then become a "concert drug" because many nightclub users use it.
This drug drowns the nervous system with serotonin and gives its users a feeling of euphoria that can last for several hours. It is generally used at night by party-goers, as it keeps them awake and alive, despite the damage done, such as memory, sleep, etc.
First experience
According to Haaretz, the new drug has been approved to be administered to 50 patients in Israel according to a deliberate program for people with PTSD, the program to begin in six months, with hundreds of applications expected.
Among those suffering from PTSD, there are soldiers returning from battlefields, and one study found that 11 to 20 per cent of US soldiers serving in Iraq were suffering from PTSD.
The reasons for the decision
The decision to resort to "ecstasy" after the Israeli Ministry of Health conducted a thorough investigation and sent representatives of the training to the United States, including a company specializing in psychological studies, and after studied the results of studies on the impact of positive property
It is likely that Israel will recognize the drug even before the United States recognizes it in 2021, which the US Food and Drug Administration is currently testing.
A study published in 2018 that concluded that the use of "hallucinogenic drugs" regularly reduced the symptoms of the disease, which followed a shock.
